UPDATE 1-Blockbuster drug Humira's sales drive AbbVie's profit

July 29 (Reuters) - AbbVie Inc posted higher-than-expected quarterly profit and revenue, driven by demand for flagship drug Humira, and raised its earnings forecast for the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.